02 June 2022 | News
Investing approx $200 million over five years and hiring more than 500 full-time employees
image credit- businesswire
US-based Insulet Corporation, a global leader in tubeless insulin pump technology with its Omnipod brand of products, is hosting a groundbreaking ceremony for its new manufacturing facility in Malaysia, further strengthening its global manufacturing capabilities.
The new manufacturing facility, located in Johor Bahru, will produce the company’s Omnipod Insulin Management System and include approximately 400,000 square feet of manufacturing space.
Insulet plans to invest approximately $200 million over five years and hire more than 500 full-time employees once the facility is operating at full capacity.
The architectural design of the facility includes sustainable elements that qualify for Green Building Initiative (GBI) and Leadership in Energy and Environmental Design (LEED) certification. Insulet’s regional sourcing strategy includes the use of local suppliers for component parts to support the Company’s global expansion.
Insulet expects the manufacturing facility to be operational by the middle of 2024.
Lee Ting Han, Johor State Investment, Trade and Consumer Affairs Committee Chairman said, “This project validates Johor’s attractiveness as a top international investment destination. We believe this new facility will play an important role in the development of the State, driving the economy and creating jobs.